Factors Related to Anxiety, Depressive Symptoms and Quality of Life in Breast Cancer
Open Access
- 16 March 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (6) , 3547
Abstract
Breast cancer (BC) is a major public health problem internationally. Although illness survival rates have improved, patients usually suffer multiple symptoms, both physical and psychological, which can affect their quality of life (QoL). The main aim of this study was to evaluate depressive symptoms, anxiety and the QoL of people with BC. An observational, cross-sectional study was carried out at Badajoz University Hospital (Spain). A total of 200 women with BC were included. EORTC QLQ-C30 and QLQ-BR23 questionnaires were used to assess QoL. Patients were screened for depressive symptoms using the Beck Depression Inventory (BDI) and for state anxiety and trait anxiety using the State Anxiety Inventory (STAI). Thirty-eight percent of the patients in the sample had moderate to severe anxiety, which was related to the time of diagnosis, advanced stage of illness and surgical treatment. We found that 28% of patients had depressive symptoms, related mainly with time of diagnosis, adjuvant therapy and number of cycles of chemotherapy (CT). Patients with the longest time since diagnosis, in stage III, and in treatment with CT, especially those with the greatest number of cycles, had the worst scores in QoL. We found a positive association between depressive symptoms and anxiety with QoL in patients with BC.Keywords
Funding Information
- Government of Extremadura (IB18101)
This publication has 55 references indexed in Scilit:
- Depression and quality of life before and after breast cancer diagnosis in older women from the Women’s Health InitiativeJournal of Cancer Survivorship, 2015
- Prospective Longitudinal Evaluation of a Symptom Cluster in Breast CancerJournal of Pain and Symptom Management, 2014
- Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?Journal of Clinical Oncology, 2011
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011
- The Symptom Cluster of Fatigue, Pain, Anxiety, and Depression and the Effect on the Quality of Life of Women Receiving Treatment for Breast Cancer: A Multicenter StudyOncology Nursing Forum, 2009
- The Course of Anxiety and Depression in Patients with Breast Cancer and Gynaecological CancerBreast Care, 2008
- Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up studyBMC Cancer, 2008
- The eortc QLQ‐C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patientsPsycho-Oncology, 2002
- Quality of life research within the EORTC—the EORTC QLQ-C30European Journal of Cancer, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993